Zobrazeno 1 - 10
of 34
pro vyhledávání: '"P J, Thuluvath"'
Publikováno v:
Annals of Hepatology, Vol 29, Iss 4, Pp 101508- (2024)
Introduction and Objectives: Sarcopenia is a common complication of end-stage liver disease (ESLD), but its exact relationship to myosteatosis and frailty remains unclear. In this pilot study, we tested the feasibility of a specialized MRI protocol a
Externí odkaz:
https://doaj.org/article/906bdb1a8f0e4b77bfb2c9454df4ac52
Publikováno v:
Annals of Hepatology, Vol 28, Iss 3, Pp 101084- (2023)
Introduction and Objectives: Although hyponatremia and hepatic encephalopathy (HE) are known independent predictors of mortality, their combined effect is unknown. We investigated whether the inpatient mortality differed among patients with both hypo
Externí odkaz:
https://doaj.org/article/52d8e140b6d94e8c817efd0435c68fb2
Autor:
Sergey V. Kantsevoy, MD, PhD, FJGES, Gordon Robbins, MD, Amit Raina, MD, Paul J. Thuluvath, MD
Publikováno v:
VideoGIE, Vol 7, Iss 7, Pp 265-267 (2022)
Externí odkaz:
https://doaj.org/article/60177818829f47dfb4e86d808f192ef4
Publikováno v:
Annals of Hepatology, Vol 27, Iss 4, Pp 100702- (2022)
Introduction and Objectives: Lower antibody (Ab) responses after SARS-CoV-2 vaccination have been reported in liver transplant (LT) recipients and those with chronic liver diseases (CLD). The role of a booster dose in those with poor responses to ini
Externí odkaz:
https://doaj.org/article/0f208867f61e496f804db29a58179fc7
Autor:
Avesh J. Thuluvath, MD, Joseph C. Ahn, MD, Puru Rattan, MD, Ahmed T. Kurdi, MD, Thoetchai B. Peeraphatdit, MD, Marielle J. Kamath, BS, Ryan J. Lennon, MS, John J. Poterucha, MD, Bret T. Petersen, MD, Patrick S. Kamath, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 2, Pp 377-387 (2021)
Objective: To determine the prevalence of Charcot triad, Reynolds pentad, and Tokyo Guidelines criteria and clinical outcomes among patients with cholangitis across different age groups. Patients and Methods: We conducted a retrospective analysis of
Externí odkaz:
https://doaj.org/article/e0f4d97c7b114d588ccbb6ab734331f8
Publikováno v:
VideoGIE, Vol 4, Iss 3, Pp 136-139 (2019)
Externí odkaz:
https://doaj.org/article/23a9fa8d746f45c5b2a97d19412de08a
Autor:
Naeem Goussous, MD, Wen Xie, MD, Talan Zhang, MS, Saad Malik, MD, Josue Alvarez-Casas, MD, Stephen H. Gray, MD, Rolf N. Barth, MD, Paul J. Thuluvath, MD, John C. LaMattina, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 12, p e788 (2021)
Background. Acute on chronic liver failure (ACLF) carries a poor prognosis unless liver transplantation is offered. We present risk factors associated with proceeding with liver transplantation in patients with ACLF. Methods. A retrospective review o
Externí odkaz:
https://doaj.org/article/6f595fdd775342ab872f093f08049894
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244744 (2020)
Background and objectivesHispanics are the fastest growing population in the USA, and our objective was to determine their waitlist mortality rates, liver transplantation (LT) rates and post-LT outcomes.MethodsAll adults listed for LT with the UNOS f
Externí odkaz:
https://doaj.org/article/e91eacdc49db410e9c0ffffddf2adb04
Autor:
Sergey V. Kantsevoy, MD, PhD, Andrej Wagner, MD, Aleksandr A. Mitrakov, MD, Avesh J. Thuluvath, MD, Frieder Berr, MD
Publikováno v:
VideoGIE, Vol 4, Iss 4, Pp 179-181 (2019)
Externí odkaz:
https://doaj.org/article/fed84f5b5e1845b3b5d26aab66819243
Autor:
Maribel Rodriguez-Torres, Eric Läwitz, Bienvenido Yangco, Lennox Jeffers, Steven-Huy Han, Paul J. Thuluvath, Vinod Rustgi, Stephen Harrison, Reem Ghalib, John M. Vierling, Velimir Luketic, Philippe J. Zamor, Natarajan Ravendhran, Timothy R. Morgan, Brian Pearlman, Christopher O’Brien, Hicham Khallafi, Nikolaos Pyrsopoulos, George Kong, Fiona McPhee, Philip D. Yin, Eric Hughes, Michelle Treitel
Publikováno v:
Annals of Hepatology, Vol 15, Iss 6, Pp 834-845 (2016)
Background. Patient race and ethnicity have historically impacted HCV treatment response. This phase 3 study evaluated daclatasvir with peginterferon-alfa-2a/ribavirin (pegIFN alfa-2a/RBV) in treatment-naive black/African American (AA), Latino, and w
Externí odkaz:
https://doaj.org/article/758320977acf45fe990b1d476981cdbb